Table 13Strength of evidence about comparative test performance in women at average risk of breast cancer

OutcomeComparison or Biopsy MethodOverall RatingKey Findings and Comments
Test performance of individual biopsy methodsFreehandLow– Sensitivity: 0.91 (0.80 to 0.96)
– Specificity: 0.98 (0.95 to 1.00)
Ultrasound, automatedModerate– Sensitivity: 0.99 (0.98 to 0.99)
– Specificity: 0.97 (0.95 to 0.98)
Ultrasound, vacuum-assistedModerate– Sensitivity: 0.97 (0.92 to 0.99)
– Specificity: 0.98 (0.96 to 0.99)
Stereotactically guided, automatedModerate– Sensitivity: 0.97 (0.95 to 0.98)
– Specificity: 0.97 (0.96 to 0.98)
Stereotactically guided, vacuum-assistedModerate– Sensitivity: 0.99 (0.98 to 0.99)
– Specificity: 0.92 (0.89 to 0.94)
MRI-guided, automatedInsufficient– Sensitivity: 0.90 (0.57 to 0.99)
– Specificity: 0.99 (0.91 to 1.00)
MRI-guided, vacuum-assistedInsufficient– Sensitivity: 1.00 (0.98 to 1.00)
– Specificity: 0.91 (0.54 to 0.99)
Comparison of test performance among alternative biopsy methodsUltrasound-guided, automated vs. vacuum-assistedLow– Difference in sensitivity: 0.01 (−0.01 to 0.06) [no difference]
– Difference in specificity: −0.01 (−0.03 to 0.01) [no difference]
Stereotactically guided, automated vs. vacuum-assistedLow– Difference in sensitivity: −0.02 (−0.04 to −0.01) [vacuum-assisted is better]
– Difference in specificity: 0.05 (0.02 to 0.08) [automated is better]
MRI-guided, automated vs. vacuum-assistedInsufficient– Difference in sensitivity: −0.10 (−0.43 to −0.01) [vacuum-assisted is better]
– Difference in specificity: 0.07 (−0.03 to 0.43) [no difference]
Modifiers of test performance for women at average and high risk of breast cancerAll biopsy methodsInsufficient– Few studies provided within-sample information for each modifier of interest; meta-regression results rely on cross-study comparisons so consistency of effects cannot be assessed
– Within-study (direct) evidence was sparse; between study evidence relied on indirect comparisons across studies
– In meta-regression analyses CrIs were wide; extreme odds ratio values were often observed because sensitivity and specificity for all tests were very close to 1 (see Results)

CrIs = credible interval; MRI = magnetic resonance imaging.

From: Discussion

Cover of Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions
Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report [Internet].
Comparative Effectiveness Reviews, No. 139.
Dahabreh IJ, Wieland LS, Adam GP, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.